✦ LIBER ✦

Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial

✍ Scribed by Monk, Bradley J.; Kaye, Stanley B.; Poveda, Andrés; Herzog, Thomas J.; Aracil, Miguel; Nieto, Antonio; Badri, Nadia; Parekh, Trilok V.; Tanović, Adnan; Galmarini, Carlos M.

Book ID: 123578568
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 362 KB
Volume: 132
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2013.10.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8005 Correlation of RNA expression of DN

8005 Correlation of RNA expression of DNA repair genes with clinical outcomes of advanced ovarian cancer (OC) pts treated with pegylated liposomal doxorubicin (PLD) vs Trabectedin (T) + PLD in the ET743-OVA-301 clinical trial

✍ Poveda, A.; Kaye, S.; Herzog, T.; Ghatage, P.; Meerpohl, H.; Ngan, H.; Emerich, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Phase III Trial of Vandetanib Compared W

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Natale, R. B.; Thongprasert, S.; Greco, F. A.; Thomas, M.; Tsai, C.-M.; Sunpawer 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 298 KB

Impact of age on outcome in patients wit

Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Pauline Wimberger; Nils Lehmann; Rainer Kimmig; Alexander Burges; Werner Meier; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 226 KB

8029 POSTER Health-Related Quality of Li

8029 POSTER Health-Related Quality of Life (HRQoL)/Patient Reported Outcomes (PRO) of Patients (pts) With Partially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Treated in a Randomized Phase III Trial of Trabectedin and Pegylated Liposomal Doxorubicin (PLD) Vs PLD Alone (OVA-301) – an Exploratory Analysis

✍ Verqote, I.; Bidzinski, M.; Kelley, J.; Vasanthan, S.; Runnebaum, I.; Vermorken, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Erlotinib Plus Gemcitabine Compared With

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

✍ Moore, M. J.; Goldstein, D.; Hamm, J.; Figer, A.; Hecht, J. R.; Gallinger, S.; A 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 357 KB

Tallimustine is inactive in patients wit

Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group

✍ Viallet, J.; Stewart, D.; Shepherd, F.; Ayoub, J.; Cormier, Y.; DiPietro, N.; St 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 415 KB